Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
How would you approach the treatment of crescentic fibrillary glomerulonephritis?
Related Questions
How do you address patient concerns regarding the necessity of REMS monitoring when prescribing sparsentan?
How do you counsel patients who are found to have a carrier mutation in a single high-risk APOL1 allele?
How do you decide when to stop immunosuppression in a patient with granulomatosis with polyangiitis who is on dialysis, has not yet recovered renal function, but has shown improvement in ANCA levels?
How would you tailor immunosuppression in an elderly patient presenting with primary FSGS?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
What is your approach to treating IgA nephropathy in patients who also have IgA vasculitis?
Do you modify the albumin level below which you would prophylactically anticoagulate a pregnant patient with nephrotic-range proteinuria, given that hypoalbuminemia is expected in pregnancy?
Under what circumstances would you consider treating with steroid therapy in a patient with HIV-associated nephropathy?
How do you manage oral prednisone when initiating nefecon in a patient with IgA nephropathy?
